$10 Billion Deal, page-175

HIV DART and Emerging Viruses 2018

Dear colleagues,
It is with great pleasure that we announce the 2018 edition of “HIV DART and Emerging Viruses” will be held in Miami, Florida, USA, on November 27-29, 2018.
Antiretroviral drug development against HIV has seen many successes over the past three decades. However, despite the approval of over 25 drugs for the treatment of HIV infection, many barriers still remain unresolved. This year, we plan to address current roadblocks in the field of HIV antiretroviral therapy, cure strategies, vaccine development, treatment access, and other unmet needs. As well, we will address novel therapeutic advancements in the area of emerging viruses such as zika virus, dengue virus, chikungunya virus and yellow fever virus.
Through participation in a carefully designed program, delegates will be able to identify current treatment limitations and this in turn, will allow for the development of novel and innovative approaches to resolve current scientific and clinical challenges. Considering the large number of therapeutic options available for HIV treatment, clinicians and health care professionals will benefit from the opportunity to discuss the latest data with their academic peers, and stay informed with regard to the implications of the latest discoveries for their clinical practice.
Ultimately, “HIV DART and Emerging Viruses 2018” aims to bridge the gap between the latest scientific developments and routine clinical practice in the context of HIV infection and emerging viruses. We sincerely look forward to your participation in this year’s HIV DART meeting.
The Conference Chair,

Raymond Schinazi, PhD, DSc